Condition
Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Total Trials
4
Recruiting
1
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 2 (2)
Trial Status
Active Not Recruiting2
Terminated1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT04420975Phase 1Active Not Recruiting
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
NCT04751409Phase 2Recruiting
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
NCT03819985Phase 2Active Not Recruiting
Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk
NCT03727789Phase 1Terminated
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
Showing all 4 trials